Chris Roberts

Biography

 Chris Roberts has been appointed as Non-Executive Chairman of the Board of the Company, effective May 8th 2017. Dr. Roberts has over 40 years’ experience in the medical innovations space, having forged a long and successful career as both a director and senior executive of ASX listed companies, research institutions, and government entities. In January 2017 Dr Roberts was appointed an Officer in the Order of Australia for his service to science and the development and commercialisation ofmedical biotechnology. He was Chief Executive Officer/President of Cochlear Limited (ASX:COH) from February 2004 to August 2015. Cochlear is the global leader in implantable devices for the hearing impaired. Dr Roberts was also previously Chairman of Sirtex Medical Ltd (ASX: SRX), from March 2000 – December 2002, and was Executive Vice-President of global sleep disorder treatment company ResMed Inc (NYSE: RMD, ASX: RMD) from 1992-2004. He is currently a Non-Executive Director of ResMed Inc. Dr. Roberts is a PLuS Alliance Professor appointed across 3 universities: UNSW, King’s College London and Arizona State University. Dr. Roberts holds a BE (Honours) in Chemical Engineering (UNSW), an MBA (Macquarie University) and a PhD (UNSW) and was awarded Honorary Doctor of Sciences degrees from Macquarie University and the University of NSW. He is a member of the Board of Governors of the Centenary Institute of Cancer Medicine and Cell Biology, and is an Honorary Fellow of the Australian Institute of Business and Economics at the University of Queensland. Additionally, he is a Fellow of the Academy of Technological Sciences and Engineering (FTSE), Fellow of the Australian Institute of Company Directors (FAICD) and Honorary Fellow of The Institution of Engineers Australia (FIEAust).

Research Interest

 technological sciences and biotechnology